Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Czechia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20121
20131
20151
20221
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company4
Viatris Innovation GmbH2
Baxalta now part of Shire1
Bristol-Myers Squibb1
Diamyd Medical AB1
Human Genome Sciences Inc.1
Immunovant Sciences GmbH1
Kedrion S.p.A.1
Pfizer1
X4 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases14
Lupus Erythematosus, Systemic7
Immune System Diseases5
Connective Tissue Diseases3
Arthritis, Rheumatoid1
Autoimmune Diseases of the Nervous System1
Barth Syndrome1
Blood Coagulation Disorders1
Demyelinating Diseases1
Diabetes Mellitus1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.